Genprex (GNPX) Assets Average (2017 - 2026)
Genprex (GNPX) posted quarterly Assets Average of $15.2 million for Q1 2026, up 200.62% year-over-year from $5.1 million in Q1 2025, and up 122.03% quarter-over-quarter from $6.9 million in Q4 2025.
Genprex (GNPX) Assets Average (2017 - 2026) Analysis & Trends
Genprex's Assets Average history runs 10 years deep, the most recent figure standing at $15.2 million for Q1 2026.
- In Q1 2026, Assets Average rose 200.62% year-over-year to $15.2 million; the TTM figure through Mar 2026 stood at $15.2 million (up 200.62% YoY), while the FY2025 annual figure was $7.1 million, down 3.46% from the prior year.
- Assets Average for Q1 2026 stood at $15.2 million, up from $6.9 million in the prior quarter.
- The five-year high for Assets Average was $41.1 million in Q1 2022, with the low at $3.7 million in Q3 2025.
- The 5-year median for Assets Average is $13.7 million (2023), against an average of $16.3 million.
- The sharpest annual moves came in 2024 and 2026: Assets Average sank 70.6% in 2024, then surged 200.62% in 2026.
- Genprex's Assets Average stood at $27.5 million in 2022, then sank by 50.37% to $13.7 million in 2023, then sank by 70.6% to $4.0 million in 2024, then soared by 70.84% to $6.9 million in 2025, then surged by 122.03% to $15.2 million in 2026.
- Business Quant data shows GNPX's Assets Average at $15.2 million in Q1 2026, $6.9 million in Q4 2025, and $3.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.96 Bn | 132.11 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 86.79 Bn | 78.79 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 65.22 Bn | 60.03 Bn | 1.37 Bn | - |
| 4 | Moderna | 60.20 Bn | 55.06 Bn | 52.00 Mn | 11.22 Bn |
| 5 | BeOne Medicines | 42.19 Bn | 37.09 Bn | 1.53 Bn | 8.86 Bn |
| 6 | Alnylam Pharmaceuticals | 31.43 Bn | 28.12 Bn | 992.69 Mn | 5.34 Bn |
| 7 | BioNTech SE | 28.65 Bn | 10.26 Bn | 668.28 Mn | 25.27 Bn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 2.09 Bn |
| 9 | Royalty Pharma | 27.16 Bn | 26.32 Bn | - | 19.82 Bn |
| 10 | Genprex | 1.88 Mn | -13.28 Mn | - | 18.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.23 Mn |
| Dec 31, 2025 | 6.86 Mn |
| Sep 30, 2025 | 3.70 Mn |
| Jun 30, 2025 | 4.92 Mn |
| Mar 31, 2025 | 5.07 Mn |
| Dec 31, 2024 | 4.02 Mn |
| Sep 30, 2024 | 5.26 Mn |
| Jun 30, 2024 | 9.58 Mn |
| Mar 31, 2024 | 11.62 Mn |
| Dec 31, 2023 | 13.66 Mn |
| Sep 30, 2023 | 16.28 Mn |
| Jun 30, 2023 | 19.62 Mn |
| Mar 31, 2023 | 24.20 Mn |
| Dec 31, 2022 | 27.52 Mn |
| Sep 30, 2022 | 32.26 Mn |
| Jun 30, 2022 | 36.99 Mn |
| Mar 31, 2022 | 41.14 Mn |
| Dec 31, 2021 | 44.59 Mn |
| Sep 30, 2021 | 47.53 Mn |
| Jun 30, 2021 | 49.88 Mn |